Monday 25 February 2008

Weekly BioNews 18 - 25 Feb 2008

- Bacteria Use 'Invisibility Cloak' To Hide From Human Immune System

ScienceDaily (Feb. 24, 2008)

Scientists at the University of York have characterised an important new step in the mechanism used by bacteria to evade our immune system.

A multidisciplinary research team from the Departments of Biology and Chemistry at York have been studying how bacteria capture the molecule used to make the ‘cloak’, called sialic acid.

The researchers have now discovered an enzymatic activity that helps in the more efficient capture of sialic acids released from our cell surfaces. As well as using the sialic acid to make the ‘invisibility cloak’ other bacteria use similar methods to capture sialic acid as a simple food source, so are literally eating us from the inside!

Dr Gavin Thomas, of the Department of Biology, who led the research said: "This novel enzyme, as well as other steps required for the formation of the 'invisibility cloak' that we have discovered in York, now offers the chance to develop novel antimicrobials against these bacteria."


Blood agar plate culture of Haemophilus influenzae. (Credit: CDC)


http://www.sciencedaily.com/releases/2008/02/080219102415.htm



- Genetic Mutation May Lead To Increased Autoimmunity


ScienceDaily (Feb. 25, 2008)


Scientists at The Scripps Research Institute have discovered that a mutation in a known DNA recombination mechanism may result in the onset of autoimmunity and an overexpression of autoreactive antibodies—molecules that attack the host—in animal models.


The new study highlights the role of "recombining sequence," a DNA element involved in the genetic reprogramming of immune system B cells, a process called receptor editing. These new findings could point toward a possible novel therapeutic target for autoimmune diseases such as lupus.


"This is the first mutation in which we were able to cripple receptor editing but not affect other processes," said David Nemazee, a Scripps Research scientist and professor of immunology, whose laboratory conducted the study. "This produced mice more prone to autoimmunity."


http://www.sciencedaily.com/releases/2008/02/080221170646.htm


-Human genetic variation study released


ANN ARBOR, Mich., Feb. 21 (UPI)

U.S. scientists have created the largest and most detailed global study of human genetic variation, providing insights into early human migrations.


The researchers from the University of Michigan and the National Institute on Aging said their study offers unprecedented detail, uncovering new clues to humanity's origins, characterizing more than 500,000 DNA markers in the human genome and examining variations across 29 populations on five continents.


"Our study is one of the first in a new wave of extremely high-resolution genome scans of population genetic variation," said Assistant Research Professor Noah Rosenberg, co-senior author of the study. "Now that we have the technology to look at thousands, or even hundreds of thousands, of genetic markers, we can infer human population relationships and ancient migrations at a finer level of resolution than has previously been possible."


http://www.newsdaily.com/Science/UPI-1-20080221-12060900-bc-us-genetics.xml


- Giant genome sequencing project announced


BOSTON, Jan. 22 (UPI)

A U.S.-British-led international consortium has announced the "1000 Genomes Project" to produce the most detailed map of human genetic variation to date.


The project will involve the sequencing of the genomes of at least 1,000 people from around the world to create the most medically useful human genetics picture ever produced.


Major support for the effort will be provided by the Wellcome Trust Sanger Institute in Britain, China's Beijing Genomics Institute and the National Human Genome Research Institute, part of the U.S. National Institutes of Health.


"The 1000 Genomes Project will examine the human genome at a level of detail no one has done before," said Wellcome's Richard Durbin, consortium co-chairman. "Such a project would have been unthinkable only two years ago. Today Β… it is now within our grasp."


http://www.newsdaily.com/Science/UPI-1-20080122-11535300-bc-us-genome-crn.xml


- What farmers think about GM crops


February 24, 2008 03:51 PM


Farmers are upbeat about genetically modified crops, according to new research funded by the Economic and Social Research Council (ESRC).


A group at the Open University, led by Professor Andy Lane, has taken the first systematic look at what large-scale, commodity farmers – not those mainly involved in organic growing - think about genetically-modified crops. We know how consumers, governments and the food industry regard GM, but this is the first proper look at the attitudes of the people who would use GM crops.


Lane and his colleagues found that both farmers who have been involved in GM crop trials and those who have not, regard GM as a simple extension of previous plant breeding techniques, such as those which have produced today’s established crop types. They regard GM crops as an innovation which they would assess on its merits. Their real interest is in how GM crops would work in practice and whether they can contribute to the profitability of their farms. The research suggests that these farmers do not think that GM raises any issues of principle, or that it is a matter of right or wrong.


http://www.biologynews.net/archives/2008/02/24/what_farmers_think_about_gm_crops.html


- Bacteria and nanofilters -the future of clean water technology


February 22, 2008 10:51 PM


Bacteria often get bad press, with those found in water often linked to illness and disease. But researchers at The University of Nottingham are using these tiny organisms alongside the very latest membrane filtration techniques to improve and refine water cleaning technology.


These one-celled organisms eat the contaminants present in water — whether it is being treated prior to industrial use or even for drinking — in a process called bioremediation.


The water is then filtered through porous membranes, which function like a sieve. However, the holes in these sieves are microscopic, and some are so small they can only be seen at the nanoscale. Pore size in these filters can range from ten microns — ten thousandths of a millimetre — to one nanometre — a millionth of a millimetre.


http://www.biologynews.net/archives/2008/02/22/bacteria_and_nanofilters_the_future_of_clean_water_technology.html


- Biochemists reveal details of mysterious bacterial microcompartments


February 21, 2008 10:00 PM


UCLA biochemists and colleagues have answered an important question about the structure of microcompartments — the mysterious molecular machines that seem to be present in a wide variety of pathogens and other bacteria.


In the Feb. 22 issue of the journal Science, the biochemists report how the microcompartment structure closes in three dimensions, forming a shell around the enzymes encased inside.


If scientists could prevent or disrupt the formation of these microcompartments, they could probably render the bacteria harmless, said research co-author Todd O. Yeates, UCLA professor of chemistry and biochemistry and a member of the UCLA–Department of Energy Institute of Genomics and Proteomics. They do not yet know how to do this, but the current research may provide a framework for targeting microcompartments.


http://www.biologynews.net/archives/2008/02/21/biochemists_reveal_details_of_mysterious_bacterial_microcompartments.html


- New understanding of how big molecules bind will lead to better drugs, synthetic organic materials


February 21, 2008 07:00 PM


Biological and medical research is on the threshold of a new era based on better understanding of how large organic molecules bind together and recognise each other. There is great potential for exploiting the molecular docking processes that are commonplace in all organisms to develop new drugs that act more specifically without adverse side effects, and construct novel materials by mimicking nature.


A recent workshop on Biosupramolecular Chemistry organised by the European Science Foundation (ESF) strengthened Europe’s platform for progress towards these goals by bringing together scientists in the relevant fields and identifying key research targets. The workshop also identified some applications close to fruition, including the engineering of bacteria to produce silks as strong for their thickness as spider webs. It has been a longstanding challenge to emulate the mechanical properties of spider silk, which combines stiffness and tensile strength with the ability to become elastic under high strains to protect against destruction. A recent project led by Thomas Scheibel at the Technical University of Munich is close to a solution that could have a host of practical applications ranging from biodegradable fishing line to body armour.


http://www.biologynews.net/archives/2008/02/21/new_understanding_of_how_big_molecules_bind_will_lead_to_better_drugs_synthetic_organic_materials.html

- Airline in first biofuel flight


Sunday, 24 February 2008, 15:32 GMT


The first flight by a commercial airline to be powered partly by biofuel has taken place. A Virgin Atlantic jumbo jet has flown between London's Heathrow and Amsterdam using fuel derived from a mixture of Brazilian babassu nuts and coconuts.


Environmentalists have branded the flight a publicity stunt and claim biofuel cultivation is not sustainable.


Earlier this month, Airbus tested another alternative fuel - a synthetic mix of gas-to-liquid.
Virgin boss Sir Richard Branson said the flight marked a "vital breakthrough" for the entire airline industry.


"This pioneering flight will enable those of us who are serious about reducing our carbon emissions to go on developing the fuels of the future," he said.


http://news.bbc.co.uk/2/hi/uk_news/7261214.stm


- China gene experts search for answers on diabetes


Sun Feb 24, 2008 1:46am EST


By Tan Ee Lyn


SHENZHEN, China (Reuters) - Chinese scientists are trying to find out which errant genes are responsible for diabetes and certain forms of cancer that have long plagued Chinese populations, a geneticist said.


Rising affluence, richer diets and a sedentary lifestyle have led to an alarming rise in cases of diabetes in China in recent decades, while cancers of the esophagus, lungs, breast, stomach and colon have plagued Chinese people for a much longer time.


The partly state-funded Beijing Genomics Institute (BGI), which completed the mapping out of the first Chinese human genome in 2007, is trying to figure out which genes may be responsible for these chronic and even terminal illnesses.


http://www.reuters.com/article/scienceNews/idUSHKG979120080224

Thursday 21 February 2008

Biotechnology Aging and the Pursuit of Happiness

A member of the President's Council on Bioethics, Dr. William Hurlbut discusses neuroscience research advances, lifestyle enhancement, and anti-aging therapies--focusing on the desires and goals of human beings rather than on the technologies employed.


From: uctelevision

Monday 18 February 2008

Weekly BioNews 11 - 18 Feb 2008

- Discovery Could Help Reprogram Adult Cells To Embryonic Stem Cell-like State


ScienceDaily (Feb. 15, 2008)

Harvard Stem Cell Institute (HSCI) and Massachusetts General Hospital (MGH) researchers have taken a major step toward eventually being able to reprogram adult cells to an embryonic stem cell-like state without the use of viruses or cancer-causing genes.

In a paper released online today by the journal Cell Stem Cell, Konrad Hochedlinger and colleagues report that they have discovered how long adult cells need to be exposed to reprogramming factors before they convert to an embryonic-like state, and have “defined the sequence of events that occur during reprogramming.”

This work on adult mouse skin cells should help researchers narrow the field of candidate chemicals and proteins that might be used to safely turn these processes on and off. This is particularly important because at this stage in the study of these induced pluripotent (iPS) cells, researchers are using cancer-causing genes to initiate the process, and are using retroviruses, which can activate cancer genes, to insert the genes into the target cells. As long as the work involves the use of either oncogenes or retroviruses, it would not be possible to use these converted cells in patients.

- New Approach May Render Disease-causing Staph Harmless

ScienceDaily (Feb. 16, 2008)

Researchers at the University of Illinois helped lead a collaborative effort to uncover a completely new treatment strategy for serious Staphylococcus aureus ("Staph") infections. The research, published Feb. 14 online in Science, comes at a time when strains of antibiotic-resistant Staph (known as MRSA, for methicillin-resistant S. aureus) are spreading in epidemic proportions in hospital and community settings.

Among the deadliest of all disease-causing organisms, Staph is the leading cause of human infections in the skin, soft tissues, bones, joints and bloodstream, and drug-resistant Staph infections are a growing threat. By federal estimates, more than 94,000 people develop serious MRSA infections and about 19,000 people die from MRSA in the U.S. every year. MRSA is believed to cause more deaths in the U.S. than HIV/AIDS.

Monday 11 February 2008

Weekly BioNews 4 - 11 Feb 2008

- First Documented Case Of Pest Resistance To Biotech Cotton


ScienceDaily (Feb. 8, 2008)

A pest insect known as bollworm is the first to evolve resistance in the field to plants modified to produce an insecticide called Bt, according to a new research report.

Bt-resistant populations of bollworm, Helicoverpa zea, were found in more than a dozen crop fields in Mississippi and Arkansas between 2003 and 2006.

"What we're seeing is evolution in action," said lead researcher Bruce Tabashnik. "This is the first documented case of field-evolved resistance to a Bt crop."

Bt crops are so named because they have been genetically altered to produce Bt toxins, which kill some insects. The toxins are produced in nature by the widespread bacterium Bacillus thuringiensis, hence the abbreviation Bt.


Full Article



- DNA 'barcode' revealed in plants


Anna-Marie Lever Science and nature reporter, BBC News
Wednesday, 6 February 2008, 13:48 GMT

A "barcode" gene that can be used to distinguish between the majority of plant species has been identified, say scientists.

This gene can be used to catalogue plant life as it has a slightly different code between species but is nearly identical within a species.

Species that look the same to the human eye can be told apart with a small leaf sample.
DNA barcoding is already a well-established technique in animals.

The work is reported in the Proceedings of the National Academy of Sciences journal.

- Three-parent embryo formed in lab

Tuesday, 5 February 2008, 11:13 GMT

Scientists believe they have made a potential breakthrough in the treatment of serious disease by creating a human embryo with three separate parents. The Newcastle University team believe the technique could help to eradicate a whole class of hereditary diseases, including some forms of epilepsy.

The embryos have been created using DNA from a man and two women in lab tests.

It could ensure women with genetic defects do not pass the diseases on to their children.

The technique is intended to help women with diseases of the mitochondria - mini organelles that are found within individual cells.

They are sometimes described as "cellular power plants" because they generate most of the cell's energy.

Faults in the mitochondrial DNA can cause around 50 known diseases, some of which lead to disability and death.

The scientists have created the embryo in the lab
- Faulty Fountains of Youth - Adult stem cells may contribute to aging
Patrick Barry

Skin sags. Hair grays. Organs don't work quite like they used to. A gradual wearing out and running down of the body's tissues seems an inherent part of growing older. Rejuvenation of skin, muscles, and other body parts naturally declines with the passing years.

An adult blood stem cell floats amid red blood cells in this stylized illustration. Red blood cells represent one of the many specialized cell types replenished by these stem cells. Scientists are revealing a more complex picture of the relationship between adult stem cells and the aging process.

Scientifically speaking, however, this observation is much less self-evident. Some cells in a person's body can resist the tide of aging. Consider the reproductive cells a person carries that will become the cells of newborn children who have 80-plus years of life to look forward to. Generation after generation, these reproductive cells form an unbroken line stretching for millennia.
- PARP-1 rules! Cornell scientists find how a protein binds to genes and regulates human genome

February 9, 2008 04:03 PM

Out of chaos, control: Cornell University molecular biologists have discovered how a protein called PARP-1 binds to genes and regulates their expression across the human genome. Knowing where PARP-1 is located and how it works may allow scientists to target this protein while battling common human diseases.

Their research is in a study published today (Feb.8, 2008) in the journal Science. "This finding was unexpected -- especially since it entails a broad distribution of PARP-1 across the human genome and a strong correlation of the protein binding with genes being turned on," said W. Lee Kraus, Cornell associate professor in molecular biology and the corresponding author in the published study. Kraus has a dual appointment at Cornell's Weill Medical College in New York City. "Our research won't necessarily find cures for human diseases, but it provides molecular insight into the regulation of gene expression that will gives us clues where to look next."

Kraus explains that PARP-1 and another genome-binding protein called histone H1 compete for binding to gene "promoters" (the on-off switches for genes) and, as such, act as part of a control panel for the human genome. H1 puts genes in an "off" position and PARP-1 turns them "on." The new study, said Kraus, shows that for a surprising number genes, the PARP-1 protein is present and histone H1 is not, helping to keep those genes turned on.
-Tattooing improves response to DNA vaccine

February 8, 2008 12:03 PM

A tattoo can be more than just a fashion statement – it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy.

Martin Muller and his team at the Deutsches Krebsforschungszentrum (German Cancer Research Center), Heidelberg, Germany, have shown that tattooing is a more effective way of delivering DNA vaccines than intramuscular injection. Using a coat protein from the human papillomavirus (HPV, the cause of cervical cancer) as a model DNA vaccine antigen, they compared delivery by tattooing the skin of mice with standard intramuscular injection with, and without, the molecular adjuvants that are often given to boost immune response.

The tattoo method gave a stronger humoral (antibody) response and cellular response than intramuscular injection, even when adjuvants were included in the latter. Three doses of DNA vaccine given by tattooing produced at least 16 times higher antibody levels than three intramuscular injections with adjuvant. The adjuvants enhanced the effect of intramuscular injection, but not of tattooing.
- NIAID scientists identify new cellular receptor for HIV

February 10, 2008 06:37 PM

A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

“The identification of this new receptor opens up new avenues of investigation that may help further elucidate the complex mechanisms of the pathogenesis of HIV infection,” says NIAID Director Anthony S. Fauci, M.D., chief of the Institute’s Laboratory of Immunoregulation (LIR) and senior author of the new study.

Several other immune cell receptors bind to HIV. Most important among these, the CD4 molecule, identified as an HIV receptor in 1984, functions as the principal receptor for HIV. The CCR5 and CXCR4 molecules, discovered in 1996, serve as co-receptors that HIV uses to enter its target cells. In the new study, which appears online Feb. 10, 2008 in Nature Immunology, NIAID scientists identify a cell adhesion molecule known as integrin alpha 4 beta 7 as another potentially important receptor for HIV.

Monday 4 February 2008

Weekly BioNews 28 Jan - 4 Feb 2008


- Finnish patient gets new jaw from own stem cells

Fri Feb 1, 2008 1:46pm EST


By Sami Torma


HELSINKI (Reuters) - Scientists in Finland said they had replaced a 65-year-old patient's upper jaw with a bone transplant cultivated from stem cells isolated from his own fatty tissue and grown inside his abdomen.


Researchers said on Friday the breakthrough opened up new ways to treat severe tissue damage and made the prospect of custom-made living spares parts for humans a step closer to reality.


"There have been a couple of similar-sounding procedures before, but these didn't use the patient's own stem cells that were first cultured and expanded in laboratory and differentiated into bone tissue," said Riitta Suuronen of the Regea Institute of Regenerative Medicine, part of the University of Tampere.

Full Article



- Pope says some science shatters human dignity

Thu Jan 31, 2008 9:57am EST

By Philip Pullella

VATICAN CITY (Reuters) - Pope Benedict said on Thursday that embryonic stem cell research, artificial insemination and the prospect of human cloning had "shattered" human dignity.

In an address to members of the Vatican department on doctrinal matters, Benedict said the Church had a duty to defend the "great values at stake" in the field of bioethics.

The speech was the latest in a series in which the conservative Pope has told his listeners that scientific progress should not be accepted uncritically.

Full Article


- WHO reports Tamiflu-resistant flu in U.S., Canada

Fri Feb 1, 2008 1:44pm EST

By Stephanie Nebehay

GENEVA (Reuters) - The main seasonal flu virus in the United States and Canada as well as parts of Europe shows higher resistance to the antiviral drug Tamiflu, raising questions about its potential effectiveness in a human bird flu pandemic.

The World Health Organization (WHO) reported the elevated resistance in North America on Friday, but said it was too early to know what the chances may be for increased Tamiflu resistance in the H5N1 strain of avian influenza.

It did not change its recommendation that Tamiflu be used to treat human cases of bird flu.

Full Article

Opinions – Suggestions - Remarks